<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>肺癌前沿 | wechat-feeds</title><link>http://MzAwMzIwODEwNQ.favicon.privacyhide.com/favicon.ico</link><description>传递最新肺癌信息</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 23 Feb 2021 12:24:42 +0800</pubDate><image><url>http://MzAwMzIwODEwNQ.favicon.privacyhide.com/favicon.ico</url><title>肺癌前沿 | wechat-feeds</title><link>http://MzAwMzIwODEwNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>[Nat Rev Dis]重磅综述带你深入了解小细胞肺癌</title><link>https://mp.weixin.qq.com/s/7ywD0UXplimjJhXpR3HdRQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6neStCkUa5mt56UZ79ZbYKqiaiavcuiar01nsObZ45vVnOBA2oibqmqWRxVhpgS0cNFG1aibHY8Sde2T1A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>小细胞肺癌：路在何方？]]></content:encoded><pubDate>Mon, 22 Feb 2021 19:12:12 +0800</pubDate></item><item><title>[JTCVS-述评] 临床IA期肺腺癌侵袭性“占卜图”</title><link>https://mp.weixin.qq.com/s/8NlKRCikKKYEhTQ19pE-DA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6m1KAGu1neARJ0tGLFlS7LWoFBJkhCw0JDgqzcm0bunSlmpD6XB20zowdUbJ1mcYKnW8oLuW8D1eg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>临床IA期肺腺癌侵袭性“占卜图”]]></content:encoded><pubDate>Tue, 16 Feb 2021 11:59:10 +0800</pubDate></item><item><title>“太平洋的风”PACIFIC模式是否适用于驱动基因阳性III期肺癌？</title><link>https://mp.weixin.qq.com/s/0r3PEKkNpqUbNUe0Z_8fuQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6nEgs5jYtiaq4rWOCf6xJXoGUOj3U94bA8oyPj15cAq1BWXOCXSdqLaFwuic88VmkPHTQDUBqfRWngg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>PACIFIC and EGFR+???]]></content:encoded><pubDate>Mon, 15 Feb 2021 13:28:28 +0800</pubDate></item><item><title>CheckMate 017/057的五年生存结果：Nivolumab在二线非小细胞肺癌治疗中优于多西他赛</title><link>https://mp.weixin.qq.com/s/EXCKX9IWemox2tWNhDm2TA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6k5aib5IXrojPuHf7mdIaiazqxG6VYDE3Nk14Ez8zOfrUwAc2Qdca6HrlXiaeaS2sESs5ST8MAZ2jtSA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CheckMate 017/057]]></content:encoded><pubDate>Sun, 14 Feb 2021 08:18:01 +0800</pubDate></item><item><title>[JCOG0804]：2cm以下磨砂玻璃成分为主肺结节楔形或肺段切除范围已足够</title><link>https://mp.weixin.qq.com/s/6cmy9IfAkPV1JpNc-ntisQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6lMXrBMP1OyRAZ6A6a3dr3YNoYuIvee0iazxeVDic7sgOQ2wrIAbIh9cYzZhOCQbjojusacfGusdJQw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>十年磨一剑，JCOG0804之终局]]></content:encoded><pubDate>Sat, 16 Jan 2021 17:58:50 +0800</pubDate></item><item><title>[JTCVS 2021] 肺腺癌侵袭性三维影像纹理量化模型的构建</title><link>https://mp.weixin.qq.com/s/0GP1aIgSMU37-OxwtWgT_g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6mARDsfvY6XaCibICwXGIlof3I1y9TiafiaF1Gv3KFZuZ5yo6atUwYJbelCz9iaams6dYY8ia3Mg1lH6Xg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 02 Jan 2021 17:55:06 +0800</pubDate></item><item><title>【CA】实体瘤新辅助治疗后重分期的现状与未来</title><link>https://mp.weixin.qq.com/s/Wf3IGKV_RpHETXx9R2k1uw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6nuYSI2yWGWsYymHIdMjXHvktdTHnYNEeuWwjVP2ookAlZtAZo6y6cGbrr5FT1YmVm1wPhFSpFslA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新辅助治疗后病理重分期的思考]]></content:encoded><pubDate>Mon, 07 Dec 2020 20:11:09 +0800</pubDate></item><item><title>广东省医学会肺部肿瘤学分会第二届年会</title><link>https://mp.weixin.qq.com/s/RKyiwcOArI4bg0E34ve_pQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6kQT5Xp8YmY1DAVLVJeexbELQSO7HY9ichwb9zQzG7x4Cl4BGaEQuu0uUzYwrMoeLc8TDEgcNyOdaA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>时间：2020年12月4日-2020年12月5日
地点：广州柏悦酒店]]></content:encoded><pubDate>Thu, 03 Dec 2020 15:41:17 +0800</pubDate></item><item><title>EGFR突变非小细胞肺癌脑膜转移:奥希替尼的应用及基于脑脊液biomarker的探索</title><link>https://mp.weixin.qq.com/s/ADRecBimI-y8lnjTbKowFQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6kfFViacseXjftxTZuicIDcebn53yNV1xznb3iczYK24d7KRqUS1esJwvct3HlvUcAjRseAKiblib0dx4g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>脑膜转移研究系列报道]]></content:encoded><pubDate>Mon, 16 Nov 2020 20:50:21 +0800</pubDate></item><item><title>The Sentinel: SITC 2020 Scientific Highlights</title><link>https://mp.weixin.qq.com/s/iPYQfIvDZSrzWFiF0brKUQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/P5kZfqfjU6no06oyA4xicB67saT2NX5iapRoAoZxnTL31icIwvwVaCPChFZtHsL2wHlPHBWp674a1rb3Ux4jUBWicA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2020年SITC, 科学与假设的微光，让子弹再飞一会儿]]></content:encoded><pubDate>Fri, 13 Nov 2020 18:25:25 +0800</pubDate></item></channel></rss>